Yüklüyor......
Levetiracetam Reverses Synaptic Deficits Produced by Overexpression of SV2A
Levetiracetam is an FDA-approved drug used to treat epilepsy and other disorders of the nervous system. Although it is known that levetiracetam binds the synaptic vesicle protein SV2A, how drug binding affects synaptic functioning remains unknown. Here we report that levetiracetam reverses the effec...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Public Library of Science
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3248421/ https://ncbi.nlm.nih.gov/pubmed/22220214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0029560 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|